ASPIRIN SLASHES CANCER DEATHS!
ASPIRIN may be the key to cutting cancer deaths by as much as 20 percent, according to encouraging new findings.
Researchers at Britain’s Cardiff University reviewed more than 100 studies involving about 250,000 patients with 18 different cancers — including breast, colon and prostate — and found people who took aspirin daily appeared to have around a 20 percent less likely to die.
According to the researchers, aspirin also seems to keep cancer from spreading to parts of the body from the original tumor site.
Scientists say doctors should give “serious consideration” to adding an aspirin regimen alongside traditional cancerfighting therapies.
“There is now a considerable body of evidence to suggest a significant reduction in mortality in patients with cancer who take aspirin — and that benefit appears to not be restricted to one or a few cancers,” explains study leader Professor Peter Elwood.
“However, we must also stress that aspirin is not a possible alternative to any other treatment.”
Experts caution one side effect of regularly taking aspirin is a risk of internal bleeding because of the drug’s blood-thinning properties. But the university team says there was no evidence suggesting any of the study participants experienced bleeding-related deaths.
Elwood adds, “Further research into aspirin and cancer would clearly be of great value, and new studies should be encouraged — especially if focused on some of the less common cancers.”